Premier Alternatives

FlightPath (Drug Discovery)

Berkeley, CA · Founded 2019 · Privately Held (backing)

Developer of antibiotic therapies designed to treat pathogen-driven diseases. FlightPath (Drug Discovery) is based in Berkeley, CA and was founded in 2019. Its last known valuation is $21 million. It has raised $9.7 million.

Last price · $/share
—
Implied valuation
$21.0M
Total raised
$9.7M
Last round
—

FlightPath (Drug Discovery) key facts

  • Developer of antibiotic therapies designed to treat pathogen-driven diseases.
  • FlightPath (Drug Discovery)’s last known valuation is $21.0M.
  • It has raised $9.7M; the latest was Later Stage VC ($8.1M) in Oct 2024.
  • Notable investors include Michigan Rise, Invest Detroit Ventures, Break Off Capital, Ann Arbor SPARK, First In Ventures — 8 tracked in total.
  • Status: Privately Held (backing).
Private Market View
More of FlightPath (Drug Discovery) with a free Private Market View account
  • ·Watch FlightPath (Drug Discovery): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

FlightPath (Drug Discovery) funding rounds

No rounds on record

No funding rounds for FlightPath (Drug Discovery) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

FlightPath (Drug Discovery) valuation

FlightPath (Drug Discovery)'s last known valuation is $21 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

FlightPath (Drug Discovery) investors

8 investors are on record for FlightPath (Drug Discovery), including Michigan Rise, Invest Detroit Ventures, Break Off Capital and Ann Arbor SPARK.

About FlightPath (Drug Discovery)

Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infectious bacteria in Lyme disease to limit microbiome damage and treat multiple pathogenic bacteria in both the oral and gut microbiome, enabling patients to get a new treatment to eradicate rare infectious diseases.

Sector
Healthcare
HQ
Berkeley, CA, United States
Founded
2019
Employees
2
Ownership
Privately Held (backing)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$21.0M

FlightPath (Drug Discovery)’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.